英文原著
2013 年 (平成 25 年)

01. Kim SW, Yoon SS, Suzuki R, Matsuno Y, Yi HG, Yoshida T, Imamura M, Wake A, Miura K, Hino M,Ishikawa T, Kim JS, Maeda Y, Lee JJ, Kang HJ, Lee HS, Lee JH, Izutsu K, Fukuda T, Kim CW, Yoshino
T, Ohshima K, Nakamura S, Nagafuji K, Suzumiya J, Harada M, Kim CS.
Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for
peripheral T-cell lymphomas with central review of pathology.
Leukemia, 27:1394-1440, 2013.

02. Ogino J, Asanuma H, Hatanaka Y, Matsuno Y, Gotoda H, Muraoka S, Tsuji T, Fukazawa Y, YamashiroK, Kondo N, Iwaki H, Miyokawa N, Hasegawa T.
Validity and reproducibility of Ki-67 assessment in gastrointestinal stromal tumors andleiomyosarcomas.
Pathol Int, 2013 Feb;63(2):102-107.

03. Yamasaki S, Miyagi-Maeshima A, Kakugawa Y, Matsuno Y, Ohara-Waki F, Fuji S, Morita-Hoshi Y,Mori M, Kim S-W, Mori S, Fukuda T, Tanosaki R, Shimoda T, Tobinai K, Saito D, Takaue Y, Teshima T,Heike Y.
Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem celltransplantation following reduced-intensity and myeloablative conditioning regimens.
Int J Hematol, 2013 Mar;97(3):421-426.

04. Matsumoto S, Nabeshima K, Kamei T, Hiroshima K, Kawahara K, Hata S, Marukawa K, Matsuno Y,Taguchi K, Tsujimura T.
Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescencein situ hybridization and virtual microscope system in effusion cytology.
Cancer Cytopathol. 2013 Aug;121(8):415-422.

05. Eto K, Kawakami H, Kuwatani M, Kudo T, Abe Y, Kawahata S, Takasawa A, Fukuoka M, Matsuno
Y, Asaka M, Sakamoto N.
Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patientswith unresectable pancreatic cancer.

Br J Cancer. 2013 Apr 16;108(7):1488-1494.

06. Domen H, Hida Y, Okamoto S, Hatanaka KC, Hatanaka Y, Kaga K, Tamaki N, Hirano S, Matsuno Y.
Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose
uptake on positron emission tomography.
Jpn J Clin Oncol. 2013 Sep;43(9):874-882.

07. Yoshida M, Matsuoka K, Nakazawa A, Yoshida M, Inoue T, Kishimoto H, Nakayama M, Takaba E,Hamazaki M, Yokoyama S, Horie H, Tanaka M, Gomi K, Ohama Y, Kigasawa H, Kitano Y, Uchida H,Kanamori Y, Iwanaka T, Tanaka Y.
Sacrococcygeal yolk sac tumor developing after teratoma: A clinicopathological study of pediatricsacrococcygeal germ cell tumors and a proposal of the pathogenesis of sacrococcygeal yolk sac tumors.
J Pediatr Surg, 48(4): 776-781, 2013.

08. Kuroda N, Tanaka A, Yamaguchi T, Kasahara K, Naruse K, Yamada Y, Hatanaka K, Shinohara N,Nagashima Y, Mikami S, Oya M, Hamashima T, Michal M, Hes O.
Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant

giving a critical

diagnostic pitfall in diagnosing renal oncocytic tumors.
Med Mol Morphol, 46: 49-55, 2013.

09. Hayashi T, Ishiwatari H, Yoshida M, Ono M, Sato T, Miyanishi K, Sato Y, Kobune M, Takimoto R,
Mitsuhashi T, Asanuma H, Ogino J, Hasegawa T, Sonoda T, Kato J.
Rapid on-site evaluation by endosonographer during endoscopic ultrasound-guided fine needle aspiration
for pancreatic solid masses.
J Gastroenterol Hepatol, 28(4): 656-663, 2013.

10. Yamashiro K, Shinohara T, Mitsuhashi T, Sugimura T, Taira K, Azuma M, Okuyama D, Nakajima M,Takeda H, Suzuki H.
Z-axis video for cytology database is a useful tool for the case presentation prior to the cytology trainingworkshop.
Diagn Cytopathol, 41(1): 47-52, 2013.

11. Nitta T, Mitsuhashi T, Hatanaka Y, Hirano S, Matsuno Y.

Pancreatic ductal adenocarcinomas with multiple large cystic structures:

A clinicopathologic andimmunohistochemical study of seven cases.
Pancreatology, 2013 Jul-Aug;13(4):401-408.

12. Ayumu Takahashi, Satoshi Konno, Kanako Hatanaka, Yoshihiro Matsuno, Etsuro Yamaguchi,
Masaharu Nishimura.
A case of sarcoidosis with eosinophilia in peripheral blood and bronchoalveolar lavage fluid.
Respir Med Case Rep. 2013 Feb 16;8:43-46.

13. Kinoshita R, Nam JM, Ito YM, Hatanaka KC, Hashimoto A, Handa H, Otsuka Y, Hashimoto S,Onodera Y, Hosoda M, Onodera S, Shimizu S, Tanaka S, Shirato H, Tanino M, Sabe H.
Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast
conservative therapy.
PLoS One. 2013 Oct 7;8(10):e76791. doi: 10.1371/journal.pone.0076791.
PMID:24116160

14.Honda S, Miyagi H, Suzuki H, Minato M, Haruta M, Kaneko Y, Hatanaka KC, Hiyama E, Kamijo T,Okada T, Taketomi A.
RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.
Pediatr Surg Int. 2013 Nov;29(11):1147-1152.

15. Nam JM, Ahmed KM, Costes S, Zhang H, Onodera Y, Olshen AB, Hatanaka KC, Kinoshita R,Ishikawa M, Sabe H, Shirato H, Park CC.
β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation
treated in situ breast cancer.
Breast Cancer Res. 2013;15(4):R60.

16. Kikuchi Y, Oyama-Manabe N, Manabe O, Naya M, Ito YM, Hatanaka KC, Tsutsui H, Terae S, Tamaki
N, Shirato H.
Imaging characteristics of cardiac dominant diffuse large B-cell lymphoma demonstrated with MDCTand PET/CT.
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1337-1344.

17. Suzuki M, Nakamaru Y, Akazawa S, Mizumachi T, Maeda M, Takagi D, Hatanaka KC, Fukuda S.
Nasal manifestations of immunoglobulin G4-related disease.
Laryngoscope. 2013 Apr;123(4):829-834.